Table 4.
A comparison to show the advances of this study (Wong et al.) over other recent research.
Sample/LFIA Target | Tablet device (single device type) | Study Participants | Technology | Train-Test Set | Deployment | |
---|---|---|---|---|---|---|
Turbe et al.20 | Blood Serum/HIV antibody | Tablet device (single device type) | 60 Field Workers | MobileNet v2 | 11,374 | 40 tests in the field |
LFD AI Consortium (Beggs, corr author)21, Lancet, 2021. | Nasopharyngeal Swab/ SARS-CoV-2 antigen | Expert Operator + participant at-home testing | Asymptomatic, provider-led community testing and NHS workers at home. | Multiple networks | 115,316 | Unknown |
Mendels et al.22 | Blood Serum/SARS-CoV-2 antibody | Custom Stand with fixed distance/pose to camera; 3 image capture types, multiple LFIAs. | Not specified | Multiple networks | 4344 | N/A |
Wong (this paper) | Blood Serum/ SARS-CoV-2 antibody | Hand-held camera, multiple capture types, untrained users, multiple LFIA types. | Lay population self-testing | Multiple networks | 1936 | 500,000+ in the field |